Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Text availability
Article attribute
Article type
Publication date

Search Results

156 results
Filters applied: . Clear all Results are displayed in a computed author sort order. Results by year timeline is unavailable
Page 1
Activation of the cannabinoid receptor by delta 9-tetrahydrocannabinol reduces gamma-aminobutyric acid uptake in the globus pallidus.
Maneuf YP, Nash JE, Crossman AR, Brotchie JM. Maneuf YP, et al. Among authors: crossman ar. Eur J Pharmacol. 1996 Jul 18;308(2):161-4. doi: 10.1016/0014-2999(96)00326-3. Eur J Pharmacol. 1996. PMID: 8840127
Chemical signalling in the globus pallidus in parkinsonism.
Brotchie J, Crossman A, Mitchell I, Duty S, Carroll C, Cooper A, Henry B, Hughes N, Maneuf Y. Brotchie J, et al. Prog Brain Res. 1993;99:125-39. doi: 10.1016/s0079-6123(08)61342-4. Prog Brain Res. 1993. PMID: 7906423 Review. No abstract available.
Modulation of GABA transmission by diazoxide and cromakalim in the globus pallidus: implications for the treatment of Parkinson's disease.
Maneuf YP, Duty S, Hille CJ, Crossman AR, Brotchie JM. Maneuf YP, et al. Among authors: crossman ar. Exp Neurol. 1996 May;139(1):12-6. doi: 10.1006/exnr.1996.0075. Exp Neurol. 1996. PMID: 8635558
Acute and chronic behavioural sequelae resulting from intrastriatal injection of an NMDA agonist.
Black MD, Crossman AR, Hayes AG, Elliott PJ. Black MD, et al. Among authors: crossman ar. Pharmacol Biochem Behav. 1994 Jun;48(2):441-6. doi: 10.1016/0091-3057(94)90550-9. Pharmacol Biochem Behav. 1994. PMID: 8090812
The role of striatopallidal neurones utilizing gamma-aminobutyric acid in the pathophysiology of MPTP-induced parkinsonism in the primate: evidence from [3H]flunitrazepam autoradiography.
Robertson RG, Clarke CA, Boyce S, Sambrook MA, Crossman AR. Robertson RG, et al. Among authors: crossman ar. Brain Res. 1990 Oct 29;531(1-2):95-104. doi: 10.1016/0006-8993(90)90762-z. Brain Res. 1990. PMID: 2289139
Stimulation of cannabinoid receptors reduces levodopa-induced dyskinesia in the MPTP-lesioned nonhuman primate model of Parkinson's disease.
Fox SH, Henry B, Hill M, Crossman A, Brotchie J. Fox SH, et al. Mov Disord. 2002 Nov;17(6):1180-7. doi: 10.1002/mds.10289. Mov Disord. 2002. PMID: 12465055
Effects of adenosine A1, dopamine D1 and metabotropic glutamate 5 receptors-modulating agents on locomotion of the reserpinised rats.
Ismayilova N, Crossman A, Verkhratsky A, Brotchie J. Ismayilova N, et al. Eur J Pharmacol. 2004 Aug 23;497(2):187-95. doi: 10.1016/j.ejphar.2004.06.030. Eur J Pharmacol. 2004. PMID: 15306204
Levetiracetam improves choreic levodopa-induced dyskinesia in the MPTP-treated macaque.
Bezard E, Hill MP, Crossman AR, Brotchie JM, Michel A, Grimée R, Klitgaard H. Bezard E, et al. Among authors: crossman ar. Eur J Pharmacol. 2004 Feb 6;485(1-3):159-64. doi: 10.1016/j.ejphar.2003.11.065. Eur J Pharmacol. 2004. PMID: 14757136
Randomised, double-blind, placebo-controlled trial to assess the potential of cannabinoid receptor stimulation in the treatment of dystonia.
Fox SH, Kellett M, Moore AP, Crossman AR, Brotchie JM. Fox SH, et al. Among authors: crossman ar. Mov Disord. 2002 Jan;17(1):145-9. doi: 10.1002/mds.1280. Mov Disord. 2002. PMID: 11835452 Clinical Trial.
Effects of CB1 cannabinoid receptor modulating compounds on the hyperkinesia induced by high-dose levodopa in the reserpine-treated rat model of Parkinson's disease.
Segovia G, Mora F, Crossman AR, Brotchie JM. Segovia G, et al. Among authors: crossman ar. Mov Disord. 2003 Feb;18(2):138-49. doi: 10.1002/mds.10312. Mov Disord. 2003. PMID: 12539206
156 results
You have reached the last page of results. A maximum of 10,000 results are available.
Jump to page
Feedback